Regulated turnover of a cell surface-associated pool of newly synthesized apolipoprotein E in HepG2 cells

Journal of Lipid Research

Volumn 40, Issue 1, 1999, Pages 39-49

  Schmitt, Matthias ^a   Grand Perret, Thierry ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Apolipoprotein E; Cell surface; HepG2 cells; Proteolysis; Secretion; Secretion recapture model

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ARTICLE; CELL STRAIN HEPG2; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; LIVER METABOLISM; LYSOSOME; MODEL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; STEADY STATE; TURNOVER TIME;

APOLIPOPROTEINS E; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL MEMBRANE; CULTURE MEDIA; ENDOCYTOSIS; ENDOPEPTIDASES; HUMANS; LIGANDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIVER; LYSOSOMES; MODELS, BIOLOGICAL;

EID: 0032930120     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
2. St. Clair, R. W., and U. Beisiegel. 1997. What do all the apolipoprotein E receptors do? Curr. Opin. Lipidol. 8: 243-245.
3. t 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J. Biol. Chem. 258: 4526-4533.
4. Mahley, R. W., and T. L. Innerarity. 1983. Lipoprotein receptors and cholesterol homeostasis. Biochim. Biophys. Acta. 737: 197-222.
5. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K. K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341: 162-164.
6. Jingami, H., and T. Yamamoto. 1995. The VLDL-receptor: wayward brother of the LDL-receptor. Curr. Opin. Lipidol. 6: 104-108.
7. Yamamoto, T., and H. Bujo. 1996. Close encounters with apoE receptors. Curr. Opin. Lipidol. 7: 298-302.
8. Wu, A. L., and H. G. Windmueller. 1979. Relative contributions by liver and intestine to individual plasma apolipoproteins. J. Biol. Chem. 254: 7316-7322.
9. Williams, D. L., P. A. Dawson, T. C. Newman, and L. L. Rudel. 1985. Synthesis of apolipoprotein E by peripheral tissues: potential functions in reverse cholesterol transport and cellular cholesterol metabolism. Ann. NY Acad. Sci. 454: 222-229.
10. Lin, C., Y. Xu, J. Wu, and L. Chan. 1986. Immunoreactive apolipoprotein E is a widely distributed cellular protein: immunohistochemical localization of apolipoprotein E in baboon tissues. J. Clin. Invest. 78: 947-958.
11. Basu, S. K., J. L. Goldstein, and M. S. Brown. 1983. Independent pathways for cholesterol and apolipoprotein E by macrophages. Science. 219: 871-873.
12. Zannis, V. I., J. McPherson, G. Goldberger, S. K. Karathanasis, and J. L. Breslow. 1984. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. J. Biol. Chem. 259: 5495-5499.
13. Zannis, V. I., J. van der Spek, and D. Silverman. 1986. Intracellular modifications of human apolipoprotein E. J. Biol. Chem. 261: 13415-13421.
14. Zannis, V. I., S. K. Karathanasis, G. M. Forbes, and J. L. Breslow. 1986. Intra- and extracellular modifications of apolipoproteins. Methods Enzymol. 128: 690-712.
15. 3 in mouse macrophages. J. Lipid Res. 32: 783-792.
16. Ye, S. Q., L. M. Olson, C. A. Reardon, and G. S. Getz. 1992. Human plasma lipoproteins regulate apolipoprotein E secretion from a post-Golgi compartment. J. Biol. Chem. 267: 21961-21966.
17. Lilly-Stauderman, M., T. L. Brown, A. Balasubramaniam, and J. A. K. Harmony. 1993. Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells. J. Lipid Res. 34: 190-200.
18. Boyles, J. K., R. E. Pitas, E. Wilson, R. W. Mahley, and M. J. Taylor. 1985. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76: 1501-1513.
19. Hamilton, R. L., J. S. Wong, L. S. S. Guo, S. Krisans, and R. J. Havel. 1990. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J. Lipid Res. 31: 1589-1603.
20. Leblond, L., and Y. S. Marcel. 1993. Uptake of high density lipoprotein cholesterol ester by HepG2 cells involves apolipoprotein E localized on the cell surface. J. Biol. Chem. 268: 1670-1676.
21. Dahan, S., J. P. Ahluwalia, L. Wong, B. I. Posner, and J. J. M. Bergeron. 1994. Concentration of intracellular hepatic apolipoprotein E in Golgi apparatus saccular distensions and endosomes. J. Cell Biol. 127: 1859-1869.
22. Han, S-H., G. Einstein, K. H. Weissgraber, W. J. Strittmatter, A. M. Saunders, M. Pericak-Vance, A. D. Roses, and D. E. Schmechel. 1994. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53: 535-544.
23. Ji, Z-S., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
24. Rusinol, A. E., Z. Cui, M. H. Chen, and J. E. Vance. 1994. A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J. Biol. Chem. 269: 27494-27502.
25. Shimano, H., Y. Namba, J. Ohsuga, M. Kawamura, K. Yamamoto, M. Shimada, T. Gotoda, K. Harada, Y. Yazaki, and N. Yamada. 1994. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. J. Clin. Invest. 93: 2215-2223.
26. Deng, J., V. Rudick, and L. Dory. 1995. Lysosomal degradation and sorting of apolipoprotein E in macrophages. J. Lipid Res. 36: 2129-2140.
27. Deng, J., V. Rudick, M. Rudick, and L. Dory. 1997. Investigation of plasma membrane-associated apolipoprotein E in primary macrophages. J. Lipid Res. 38: 217-227.
28. Lucas, M., and T. Mazzone. 1996. Cell surface proteoglycans modulate net synthesis and secretion of macrophage apolipoprotein E. J. Biol. Chem. 271: 13454-13460.
29. Wong, L. 1989. Contribution of endosomes to intrahepatic distribution of apolipoprotein B and apolipoprotein E. J. Cell. Physiol. 141: 441-452.
30. Krisans, S. K. 1992. The role of peroxisomes in cholesterol metabolism. Am. J. Respir. Cell Mol. Biol. 7: 358-364.
31. Schwiegelshohn, B., J. F. Presley, M. Gorecki, T. Vogel, Y. A. Carpentier, F. R. Maxfield, and R. J. Deckelbaum. 1995. Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J. Biol. Chem. 270: 1761-1769.
32. Mazzone, T., L. Pustelnikas, and C. A. Reardon. 1992. Post-translational regulation of macrophage apoprotein E production. J. Biol. Chem. 267: 1081-1087.
33. Ye, S. Q., C. A. Reardon, and G. S. Getz. 1993. Inhibition of apolipoprotein E degradation in a post-Golgi compartment by a cysteine protease inhibitor. J. Biol. Chem. 268: 8497-8502.
34. Duan, H., C-Y. Lin, and T. Mazzone. 1997. Degradation of macrophage apoE in a nonlysosomal compartment. Regulation by sterols. J. Biol. Chem. 272: 31156-31162.
35. Brown, M. S., J. Herz, R. C. Kowal, and J. L. Goldstein. 1991. The low-density lipoprotein receptor-related protein: double agent or decoy? Curr. Opin. Lipidol. 2: 65-72.
36. Mahley, R. W., and M. M. Hussain. 1991. Chylomicron and chylomicron remnant metabolism. Curr. Opin. Lipidol. 2: 170-176.
37. Mahley, R. W., Z-S. Ji, W. J. Brecht, R. D. Miranda, and D. He. 1994. Role of heparan sulfate proteoglycans and the LDL-rereptor-related protein in remnant lipoprotein metabolism. Ann. NY Acad. Sci. 737: 39-52.
38. Cooper, A. D. 1997. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38: 2173-2192.
39. Willnow, T. E. 1997. Mechanisms of hepatic chylomicron remnant clearance. Diabetic Med. 14: 75-80.
40. Ji, Z-S., S. Fazio, Y-L. Lee, and R. W. Mahley. 1994. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269: 2764-2772.
41. Willnow, T. E., Z. Sheng, S. Ishibashi, and J. Herz. 1994. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science. 264: 1471-1474.
42. Ji, Z-S., D. A. Sanan, and R. W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J. Lipid Res. 36: 583-592.
43. Van Eck, M., N. Herijgers, J. Yates, N. J. Pearce, P. M. Hoogerbrugge, P. H. E. Groot, and T. J. C. Van Berkel. 1997. Bone marrow transplantation on apolipoprotein E-deficient mice. Effect of apoE gene dosage on serum lipid concentrations. (β)VLDL catabolism. and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17: 3117-3126.
44. Knowles, B. B., C. C. Howe, and D. P. Aden. 1980. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 209: 497-499.
45. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
46. Noel, S-P., L. Wong, P. J. Dolphin, L. Dory, and D. Rubinstein. 1979. Secretion of cholesterol-rich lipoproteins by perfused livers of hypercholesterolemic rats. J. Clin. Invest. 64: 674-683.
47. Krul, E. S., P. J. Dolphin, and D. Rubinstein. 1981. Secretion of nascent lipoproteins by isolated rat hepatocytes. Can. J. Biochem. 59: 676-686.
48. Davis, R. A., S. M. Dluz, J. K. Leighton, and V. A. Brengaze. 1989. Increased translatable mRNA and decreased lipogenesis are responsible for the augmented secretion of lipid-deficient apolipoprotein E by hepatocytes from fasted rats. J. Biol. Chem. 264: 8970-8977.
49. Tam, S-P., and R. Ramharack. 1992. The effect of 25-hydroxycholesterol on the regulation of apolipoprotein E mRNA levels and secretion in the human hepatoma HepG2. Atherosclerosis. 95: 137-146.
50. Weissgraber, K. H. 1990. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31: 1503-1511.
51. Fazio, S., Z. Yao, B. J. McCarthy, and S. C. Rall. 1992. Synthesis and secretion of apolipoprotein E occur independently of synthesis and secretion of apolipoprotein B-containing lipoproteins in HepG2 cells. J. Biol. Chem. 267: 6941-6945.
52. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
53. Fuki, I. V., K. M. Kuhn, I. R. Lomazov, V. L. Rothman, G. P. Tuszynski, R. V. Iozzo, T. L. Swenson, E. A. Fisher, and K. J. Williams. 1997. The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J. Clin. Invest. 100: 1611-1622.
54. Al-Haideri, M., I. J. Goldberg, N. F. Galeano, A. Gleeson, T. Vogel, M. Gorecki, S. L. Sturley, and R. J. Deckelbaum. 1997. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. Biochemistry. 36: 12766-12772.
55. Sasaki, T., M. Kishi, M. Saito, T. Tanaka, N. Higuchi, N. Konimani, N. Katunuma, and T. Murachi. 1990. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins. J. Enzyme Inhib. 3: 195-201.
56. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78: 761-771.
57. Goldstein, J. L., and M. S. Brown. 1974. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J. Biol. Chem. 249: 5153-5162.
58. Benoist, F., and T. Grand-Perret. 1997. Co-translational degradation of apolipoprotein B-100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein. J. Biol. Chem. 272: 20435-20442.
59. Fisher, E. A., M. Zhou, D. M. Mitchell, X. Wu, S. Omura, H. Wang, A. L. Goldberg, and H. N. Ginsberg. 1997. The degradation of apolipoprotein B-100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J. Biol. Chem. 272: 20427-20434.
60. Benoist, F., E. Nicodème and T. Grand-Perret. 1996. Microsomal triacylglycerol transfer protein prevents presecretory degradation of apolipoprotein B-100. A dithiothreitol-sensitive protease is involved. Eur. J. Biochem. 240: 713-720.
61. Boisvert, W. A., J. Spangerberg, and L. K. Curtis. 1995. Treatment of severe hypercholesteremia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96: 1118-1124.
62. Linton, M. F., J. B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apoE-deficient mice by bone marrow transplantation. Science. 267: 1034-1037.
63. Linton, M. F., A. H. Hasty, V. R. Babaev, and S. Fazio. 1998. Hepatic apoE expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. J. Clin. Invest. 101: 1726-1736.